Inventor · disambiguated record
Steven Jungles
Also filed as: JUNGLES STEVEN
12 granted patents·15 pending applications·74 citations·filing 2005–2024
90Inventor score
Files withULTRAGENYX PHARMACEUTICAL INC17INOZYME PHARMA INC5BIOMARIN PHARM INC2HENDERSON MARK1KLOPP JOHN1
Top patents by PatentIndex Score
27 records- 0190US7566462B2Stable tablet formulationBIOMARIN PHARM INC·Filed 2008·Granted Jul 28, 2009·26 cites·20 claims
- 0289US8003126B2Stable tablet formulationBIOMARIN PHARM INC·Filed 2005·Granted Aug 23, 2011·22 cites·22 claims
- 0386US2024245759A1Sialylated glycoprotein compositions and uses thereofULTRAGENYX PHARMACEUTICAL INC·Filed 2023·Application pending·0 cites
- 0486US2025120936A1Compositions of triglycerides and uses thereofULTRAGENYX PHARMACEUTICAL INC·Filed 2024·Application pending·0 cites
- 0586US2025120935A1Compositions of triglycerides and uses thereofULTRAGENYX PHARMACEUTICAL INC·Filed 2024·Application pending·0 cites
- 0685US2025120934A1Compositions of triglycerides and uses thereofULTRAGENYX PHARMACETICAL INC·Filed 2024·Application pending·0 cites
- 0784US10065981B2Sialic acid analogsULTRAGENYX PHARMACEUTICAL INC·Filed 2015·Granted Sep 4, 2018·4 cites·33 claims
- 0883US8840926B2Sialic acid analogsULTRAGENYX PHARMACEUTICAL INC·Filed 2012·Granted Sep 23, 2014·8 cites·21 claims
- 0983US8178670B2Method of synthesizing tetrahydrobiopterinHENDERSON MARK·Filed 2009·Granted May 15, 2012·6 cites·26 claims
- 1082US9221858B2Sialic acid analogsULTRAGENYX PHARMACEUTICAL INC·Filed 2014·Granted Dec 29, 2015·4 cites·35 claims
- 1177US10457701B2Sialic acid analogsULTRAGENYX PHARMACEUTICAL INC·Filed 2018·Granted Oct 29, 2019·1 cites·15 claims
- 1277US2022202915A1Sialylated glycoprotein compositons and uses thereofULTRAGENYX PHARMACEUTICAL INC·Filed 2021·Application pending·0 cites
- 1374US9687532B2Sialylated glycoprotein compositons and uses thereofULTRAGENYX PHARMACEUTICAL INC·Filed 2016·Granted Jun 27, 2017·1 cites·17 claims
- 1473US10889607B2Sialic acid analogsULTRAGENYX PHARMACEUTICAL INC·Filed 2019·Granted Jan 12, 2021·0 cites·20 claims
- 1572US9457068B2Sialylated glycoprotein compositions and uses thereofULTRAGENYX PHARMACEUTICAL INC·Filed 2015·Granted Oct 4, 2016·1 cites·9 claims
- 1671US9457067B2Sialylated glycoprotein compositions and uses thereofULTRAGENYX PHARMACEUTICAL INC·Filed 2015·Granted Oct 4, 2016·1 cites·12 claims
- 1770US2020282028A1Sialylated glycoprotein compositons and uses thereofULTRAGENYX PHARMACEUTICAL INC·Filed 2020·Application pending·0 cites
- 1868US2023031809A1Treatment of diseases involving deficiency of enpp1 or enpp3INOZYME PHARMA INC·Filed 2022·Application pending·0 cites
- 1967US2025073319A1Lyophilized enpp1 polypeptide formulations and uses thereofINOZYME PHARMA INC·Filed 2024·Application pending·0 cites
- 2064US2020069631A1Solid compositions of triglycerides and uses thereofULTRAGENYX PHARMACEUTICAL INC·Filed 2019·Application pending·0 cites
- 2163US9937243B2Sialylated glycoprotein compositions and uses thereofULTRAGENYX PHARMACEUTICAL INC·Filed 2017·Granted Apr 10, 2018·0 cites·18 claims
- 2263US2019054153A1Sialylated glycoprotein compositions and uses thereofULTRAGENYX PHARMACEUTICAL INC·Filed 2018·Application pending·0 cites
- 2361US2016243071A1Solid compositions of triglycerides and uses thereofKLOPP JOHN·Filed 2014·Application pending·0 cites
- 2460US2021187067A1Treatment of diseases involving deficiency of enpp1 or enpp3INOZYME PHARMA INC·Filed 2021·Application pending·0 cites
- 2560US2024148907A1Liver specific production of enpp1 or enpp3INOZYME PHARMA INC·Filed 2023·Application pending·0 cites
- 2656US2023313158A1Soluble enpp1 proteins and uses thereofINOZYME PHARMA INC·Filed 2022·Application pending·0 cites
- 2742US2016289175A1Creatine analogs and the use thereofULTRAGENYX PHARMACEUTICAL INC·Filed 2014·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Steven Jungles files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →